Bt474 Cells
BT474 cells are widely used in hematology and oncology research due to their potential in studying breast cancer. They are a type of epithelial cell line that were derived from the pleural effusion of a 50-year-old woman with breast carcinoma in 1974. BT-474 cells are known to overexpress the human epidermal growth factor receptor 2 (HER2), which is present in 20-30% of breast cancer patients. This feature makes them suitable for studying the mechanism of HER2 function and investigating the efficacy of HER2-targeted therapies. The cells also express estrogen receptor (ER) and progesterone receptor (PR) making them a model for hormone-dependent breast cancer. The BT474 cells can be used to investigate the efficacy of new anti-cancer drugs, screen compounds for anti-cancer activity, and study the effects of radiation therapy on HER2-positive breast cancer cells. They are also utilized in preclinical studies and drug development for breast cancer treatment. Moreover, the cells are valuable for examining cellular processes and molecular signaling pathways involved in breast cancer development and progression. Researchers can use BT474 cells to study the pathogenesis of breast cancer, identify new targets for drug discovery, and develop new diagnostic and prognostic markers for breast cancer. In conclusion, BT474 cells are a valuable resource in hematology and oncology research, owing to their potential in studying breast cancer. Their overexpression of HER2 and the presence of ER and PR make them a model for investigating the molecular mechanisms of breast cancer and the development of new anti-cancer therapies.
← Hematology Research and Oncology Research